Supriya Lifescience Share price
SUPRIYA
718.25
0.75 (0.10%)Last updated on 8 Oct, 2025 | 13:50 IST
Today's High
720.95
Today's Low
711.25
52 Week Low
511.40
52 Week High
842.00
The current prices are delayed, login to your account for live prices
LoginSupriya Lifescience Share Key Metrics
Volume
43346.00
Market Cap
5774.64 CR
LTQ@LTP
3@718.25
ATP
715.42
Var Margin
22.24 %
Circuit Range
574-861
Delivery %
42.58 %
Value
3.10 CR
ASM/GSM
No
Market Lot
1
Supriya Lifescience Fundamentals
View MoreP/E Ratio
0
P/B Ratio
0
Div. Yield
0
Sector P/E
37.89
Sector P/B
3.6
Sec. Div. Yield
0.55
Supriya Lifescience Resistance and Support
Pivot 663.63
Resistance
First Resistance
675.56
Second Resistance
695.88
Third Resistance
707.81
Support
First Support
643.31
Second Support
631.38
Third Support
611.06
Supriya Lifescience Corporate Actions
| Date | Agenda |
|---|---|
| 2025-08-13 | Quarterly Results |
| 2025-05-27 | Audited Results & Final Dividend |
| 2025-03-10 | Others |
| 2025-01-24 | Quarterly Results & Others |
| 2024-10-28 | Quarterly Results |
| 2024-08-10 | Quarterly Results |
Supriya Lifescience News
Supriya Lifescience opens new API block at Lote Parshuram site in Maharashtra
Dec 18 2024 05:42:00
About Supriya Lifescience
NSE : 7390
BSE : 543434
ISIN : INE07RO01027
The Company was incorporated as ‘Supriya Lifescience Limited’ pursuant to a certificate of incorporation dated March 26 2008 issued by the Registrar of Companies Maharashtra at Mumbai (“RoC”) upon the conversion of ‘M/s Supriya Chemicals’ a partnership firm into a public limited company in accordance with the provisions of Part IX of the Companies Act 1956. the Company commenced operations pursuant to a certificate for commencement of business dated April 1 2008 issued by the RoC.Major events and milestones of the Company :2008- Incorporation of the Company upon its conversion from a partnership firm to a public limited company2009- Started production of Ketamine Hydrochloride2010- CEP (Certificate of Sustainability) granted for Chlorphenamine Maleate2011- IDL granted for Chlorphenamine Maleate2013- COFEPRIS and KFDA approval granted2014- USFDA approval granted- IDL granted for Brompheniramine Maleate2015- EUGMP and EDQM approval granted2017- CEP (Certificate of Sustainability) granted for Pheniramine Maleate- Second time USFDA approval granted2018- CEP (Certificate of Sustainability) granted for Brompheniramine Maleate Mepyramine Maleate & Ketamine Hydrochloride2020- Third time USFDA approval2021- CEP (Certificate of Suitability) granted for Pentoxifylline Esketamine Hydrochloride and Salbutamol Sulphate- NMPA approval granted- Health Canada approvaAwards accreditations or recognitions :2009- Certificate of Excellence for outstanding Export Performance in the product group Chemicals Drugs Pharma and Allied Products (MSME) awarded by Federation of Indian Export Organisations2010- Special Recognition National Award for Research and Development awarded by Ministry of Micro Small and Medium Enterprises Government of India2016- Export House for the Year for 2015-16 awarded by Directorate of Industries Government of Maharashtra- Export Achievement for 2015-16 in the product group Basic Chemical Pharmaceutical & Cosmetics Products (MSME) awarded by Directorate of Industries Government of Maharashtra2017- Export House for the Year for 2016-17 awarded by Directorate of Industries Government of Maharashtra- Export Achievement for 2016-17 in the product group Basic Chemical & Pharmaceutical Cosmetics (SSI) awarded by Directorate of Industries Government of Maharashtra2019- Outstanding Export Performance Award for the year 2018-19 for product group API / Bulk Drugs by Pharmaceuticals Export Promotion Council of India
Supriya Lifescience Management
| Name | Position |
|---|---|
| Mr. Satish Waman Wagh | Chairman & Executive Director |
| Ms. Saloni Satish Wagh | Managing Director |